The General Hospital of Mexico is a hospital in Mexico City, operated by the Secretariat of Health, the federal government department in charge of all social health services in Mexico.

During the past decade, Hospital General de Mexico conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 11 clinical trials were completed, i.e. on average, 35.5% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 6 clinical trials were completed. i.e. 30% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital General de Mexico" #1 sponsor was "Hospital General de Mexico" with 10 trials, followed by "Hoffmann-La Roche" with 6 trials sponsored, "Hospital General de México Dr. Eduardo Liceaga" with 5 trials sponsored, "Bristol-Myers Squibb" with 4 trials sponsored and "Corporacion Parc Tauli" with 4 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital General de Mexico" #1 collaborator was "Centre de Recerca Matemàtica" with 2 trials as a collaborator, "Hospital General de México Dr. Eduardo Liceaga" with 2 trials as a collaborator, "Institut de Ciències Fotòniques (ICFO)" with 2 trials as a collaborator, "Institute of Physics University of Campinas" with 2 trials as a collaborator and "Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran" with 2 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "Hospital General de Mexico" are "HIV Infections" (4 trials), "Acute Lymphoblastic Leukemia" (3 trials), "COVID-19" (3 trials), "Covid19" (3 trials) and "Rheumatoid Arthritis" (3 trials). Many other conditions were trialed in "Hospital General de Mexico" in a lesser frequency.

Most popular intervention types in "Hospital General de Mexico" are "Drug" (33 trials), "Other" (7 trials), "Biological" (5 trials), "Diagnostic Test" (5 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Atazanavir" (2 trials), "placebo" (2 trials), "ALX1-11" (1 trials) and "ALX1-11 (drug)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital General de Mexico" are 49 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital General de Mexico". 1 are not yet recruiting, 9 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Hospital General de Mexico, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital General de Mexico, 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 8 trials that are defined as “Not Applicable".